A practical reference on lyophilisation: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-03-06 and is reviewed periodically as new material appears.
Bremelanotide is a synthetic cyclic heptapeptide developed under the research code PT-141. The code reflects its position in an internal compound series rather than a chemical classification, and the name bremelanotide was later adopted for regulatory filings. Structurally it belongs to the melanocortin peptide family and shares a core sequence motif with alpha-melanocyte-stimulating hormone. The compound is supplied as an acetate salt in aqueous solution for injection. In reference literature it is indexed under both the code and the generic name, a dual listing that can complicate database searches.
Early work on melanocortin analogs in the 1980s and 1990s produced peptides intended to influence pigmentation and appetite. One of these, melanotan II, was observed to affect sexual desire as an incidental finding in self-administration reports. Researchers then pursued analogs with altered receptor selectivity and improved handling characteristics, and PT-141 emerged from that program in the late 1990s. The development path moved from dermatology and metabolism toward a central nervous system application, a shift that shaped both trial designs and the eventual label.
Regulatory review of bremelanotide concluded in 2019 with approval in the United States for a defined indication in premenopausal women. The reviewed formulation is a single-use prefilled autoinjector given subcutaneously, and its label carries cardiovascular monitoring language tied to blood pressure changes recorded during trials. Availability outside the approving jurisdiction varies, and in several countries the compound remains unapproved or is handled as a prescription-only item. Compounded and research-grade material also circulates, and it differs from the reviewed product in purity, characterization, and chain of custody.
Lyophilised peptide is generally held below minus twenty degrees Celsius, protected from light and moisture, because hydrolysis and oxidation accumulate faster at ambient temperature. Once reconstituted, solutions are typically kept between two and eight degrees Celsius and used within a short window defined by the supplier. Repeated freeze-thaw cycles are avoided since they promote aggregation and loss of soluble material. Container material matters as well, because peptides adsorb to certain plastics and glass surfaces at low concentration. Stability figures supplied by a vendor apply only to the specific lot and buffer that were tested.
Identity and purity are usually established with reversed-phase high-performance liquid chromatography combined with mass spectrometry. A gradient of water and acetonitrile containing trifluoroacetic acid is a common mobile phase, and ultraviolet detection near 214 nanometres responds to the peptide backbone. Mass spectrometry confirms the expected molecular mass and helps reveal truncation or oxidation products. Purity is reported as a peak-area percentage, a figure that depends on the wavelength and gradient used, so values from different laboratories are not always directly comparable. Peptide mapping and amino acid analysis provide additional confirmation when required.
Regulatory status varies by jurisdiction, where approved prescription products, compounded preparations and research-grade material are treated as distinct categories with different documentation requirements. Suppliers of research material commonly issue a certificate of analysis listing purity, identity and sometimes endotoxin content. Independent verification by a third-party laboratory is often recommended because self-reported figures are difficult to check. Literature discussions usually state the source, purity and storage conditions of the material used, since these details affect reproducibility. Analysts note that a reported purity figure does not by itself describe biological activity.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C50H68N14O10 | Cyclic heptapeptide core |
| Molecular weight | 1025.2 g/mol | Calculated for the free base |
| CAS registry number | 189691-06-3 | Free base; the acetate salt has a separate entry |
| Solubility class | Water-soluble | Freely soluble in aqueous media near neutral pH |
| Typical storage | 2 to 8 °C | Protect from light; avoid repeated freeze-thaw cycles |
Bremelanotide is a synthetic cyclic heptapeptide that acts on a family of G-protein-coupled receptors. It was designed as a structural analogue of alpha-melanocyte-stimulating hormone, the endogenous peptide associated with pigmentation and several central signalling pathways. A lactam bridge constrains the ring and slows enzymatic breakdown, which distinguishes it from the linear parent molecule. Research interest moved over time from pigment biology toward central nervous system effects, particularly circuits connected to sexual desire. Parenteral delivery is used because oral bioavailability is poor.
Early clinical work used an intranasal formulation, and later programmes switched to subcutaneous delivery for more consistent absorption. A subcutaneous product received regulatory approval in the United States in 2019 for premenopausal women with acquired, generalised hypoactive sexual desire disorder. Approval followed phase 3 trials in which active treatment separated from placebo on desire and distress measures, though the average difference was modest. Labeling carries a caution about transient blood pressure elevation, so cardiovascular history is assessed before prescribing. Questions about durability of benefit beyond several months remain open.
Compared with the related compound melanotan II, PT-141 shows markedly weaker activation of receptors tied to pigmentation. This difference stems from subtle structural variations that alter affinity distribution across receptor subtypes. Investigators propose that such selectivity produces a different side effect profile in specific applications. However, downstream consequences of prolonged receptor activation remain uncertain in the literature. Published studies do not fully agree on the duration of signaling pathway activity and the mechanisms of desensitization.
From a pharmacokinetic standpoint, the peptide is usually delivered by injection because oral bioavailability is very low; proteases in the digestive tract degrade it rapidly. After subcutaneous administration, plasma concentrations reach a peak within roughly one hour. Its elimination half-life is relatively short, with most reports placing it in the range of a few hours. Nasal formulations have also been examined, though absorption varies widely between individuals. Metabolism proceeds mainly through peptidase cleavage, and the resulting products are excreted by the kidneys.
Although hydroperoxide often refers to a class of organic compounds, many inorganic or metallo-organic compounds are hydroperoxides. One example involves sodium perborate, a commercially important bleaching agent with the formula Na2[(HO)2B]2(OO)2)]. It acts by hydrolysis to give a boron-hydroperoxide: [(HO)2B]2(OO)2)2− + 2 H2O ⇌ 2 [(HO)3B(OOH)]− This hydrogen peroxide then releases hydrogen peroxide: [(HO)3B(OOH)]− + H2O ⇌ B(OH)−4 + H2O2 Several metal hydroperoxide complexes have been characterized by X-ray crystallography, for example: triphenylsilicon and triphenylgermanium hydroperoxides can be obtained by reaction of initial chlorides with excess of hydrogen peroxide in presence of base. Some form by the reaction of metal hydrides with oxygen gas: LnM−H + O2 → LnM−O−O−H (Ln refers to other ligands bound to the metal) Some transition metal dioxygen complexes abstract H atoms (and sometimes protons) to give hydroperoxides: LnM(O2) + H → LnMOOH
== Early life and education == Guillaume was born Robert Peter Williams in St. Louis to an alcoholic mother. After she abandoned him and several siblings, they were raised by their grandmother, Jeannette Williams. He studied at Saint Louis University and Washington University in St. Louis and served in the U.S. Army before pursuing an acting career. He adopted the surname Guillaume (French for William) as his stage name.
Promising innovations relating to global challenges are demonstrated: an overview of "the nascent industry of AI-designed drugs" (1 June), after moderators of the Web content aggregation-based platform Reddit strike against the site's introduction of API pricing and the ensuing closing of several mobile client apps, several novel decentralized open source aggregation platforms gain substantial numbers of users – most notably Lemmy and Kbin which can synchronize their posts via interoperability (12 June), the first upgrade of the Global Earthquake Model data for disaster risk reduction is reported (13 June), first approval for two cultured meat products in the U.S. and two of the first worldwide (21 June), transgenic soya beans containing pig protein (Piggy Sooy) are reported (28 June), a new type of glass (LionGlass) that is substantially more damage-resistant and more sustainable is reported (30 June).
Sources: en.wikipedia.org
As of January 2006, about two thirds of worldwide structural genomics (SG) output was made by PSI centers. Of these PSI contributions over 20% represented new Pfam families, compared to the non-SG average of 5%. Pfam families represent structurally distinct groups of proteins as predicted from sequenced genomes. Not targeting homologs of known structure was accomplished by using sequence comparison tools like BLAST and PSI-BLAST. Like the difference in novelty as determined by discovery of new Pfam families, the PSI also discovered more SCOP folds and superfamilies than non-SG efforts. In 2006, 16% of structures solved by the PSI represented new SCOP folds and superfamilies, while the non-SG average was 4%. Solving such novel structures reflects increased coverage of protein fold space, one of the PSI's main goals. Determining the structure a novel protein allows homology modeling to more accurately predict the fold of other proteins in the same structural family. While most of the structures solved by the four large-scale PSI centers lack functional annotation, many of the remaining PSI centers determine structures for proteins with known biological function. The TB Structural Genomics Consortium, for example, focused exclusively on functionally characterized proteins. During its term in PSI-1, it deposited structures for over 70 unique proteins from Mycobacterium tuberculosis, which represented more than 35% of total unique M. tuberculosis structures solved through 2007.
), v is the STP volume of adsorbed adsorbate, vmon is the STP volume of the amount of adsorbate required to form a monolayer, and c is the equilibrium constant K we used in Langmuir isotherm multiplied by the vapor pressure of the adsorbate. The key assumption used in deriving the BET equation that the successive heats of adsorption for all layers except the first are equal to the heat of condensation of the adsorbate. The Langmuir isotherm is usually better for chemisorption, and the BET isotherm works better for physisorption for non-microporous surfaces.
A drone attack struck industrial facilities in Yelabuga and Nizhnekamsk in the Russian republic of Tatarstan. The drones hit the Yelabuga drone factory, causing "significant damage", according to Ukrainian officials. A local Russian official denied any damage to the factory. Russian media reported a nearby workers' dormitory was damaged, injuring twelve college students, including five minors, who were employed at the drone manufactory. Other drones struck the Tatneft oil refinery in Nizhnekamsk, causing a fire that did not cause "critical damage". A Ukrainian-made light aircraft, believed to be an Aeroprakt A-22 Foxbat, was converted into a one-way drone. Another drone attack later that day damaged several buildings in Kursk. Ukrainian military intelligence (HUR) said it had blown up an electricity substation in Sevastopol, causing blackouts in the city. Two people were killed in Russian attacks in Kharkiv and Kherson Oblasts. Eighteen people were injured in a missile attack on Dnipro. Russian president Vladimir Putin appointed vice-admiral Sergei Pinchuk as commander of the Russian Black Sea Fleet. Ukrainian president Volodymyr Zelenskyy signed a law lowering the age of conscription in Ukraine from 27 years to 25. The Register of Damage Caused by the Aggression of the Russian Federation against Ukraine (RD4U), an online registry for Ukrainians to submit claims for damage caused by the Russian invasion, was officially opened, with at least 100 claims submitted in the first hours.
Sources: en.wikipedia.org
Most commercially produced dog food is made with animal feed grade ingredients and comes dry in bags (also known in the US as kibble) or wet in cans. Dry food contains 6–10% moisture by volume, as compared to 60–90% in canned food. Semi-moist products typically run 25–35%. Isotopic analysis of dog food in the Brazilian market have found that they are basically made of maize and poultry by-products.
Registered voters: 125,090 valid: 104,941 turnout: 84% The West Prussian plebiscite area remained with Germany and became part of the new West Prussia Government Region, which was annexed to East Prussia in 1922.
second messenger Also secondary messenger. A molecule or compound (often a protein) that is caused to accumulate in an effector cell by the action of a hormone, growth factor, or other agonist and thereby brings about the action of that agonist on the cell. Second messengers are therefore critical mediators of a diverse variety of signal transduction pathways, including the synthesis of cyclic AMP by adenylate cyclase and of cyclic GMP by guanylate cyclase, the opening of ion channels, and the phosphorylation of proteins by serine/threonine-specific or tyrosine-specific protein kinases.
== Further reading == Peters, U H (1992), "[Introduction of shock therapy and psychiatric emigration]", Fortschritte der Neurologie-Psychiatrie, vol. 60, no. 9 (published Sep 1992), pp. 356–365, doi:10.1055/s-2007-999155, PMID 1398417, S2CID 71208271 "Manfred J. Sakel", Journal of Clinical and Experimental Psychopathology, vol. 15, no. 3, p. 319, 1954, PMID 13221647 Fink, M (1984), "Meduna and the Origins of Convulsive Therapy", American Journal of Psychiatry, 141(9): 1034-1041 (This historical and biographical paper discusses the introduction of the shock treatment in psychiatry, the role of a theory of the biological antagonism between epilepsy and schizophrenia, and the contributions of Ladislas J. Meduna, Sakel, Ugo Cerletti, and Lucio Bini.) Doroshow, DB: Performing a Cure for Schizophrenia: Insulin Coma Therapy on the Wards. Journal of the History of Medicine and Allied Sciences, Advance Access published online on November 14, 2006 Jones, K. Insulin coma therapy in schizophrenia. J. Royal Soc. Med, 93: 147-149, 2000.
Sources: en.wikipedia.org
PT-141 was the internal development code assigned to bremelanotide during preclinical research. Reference sources sometimes index the peptide under the code rather than the generic name. The two terms describe the same molecule.
They are related but distinct cyclic peptides. Melanotan II is an earlier and less selective melanocortin analog. Bremelanotide was developed later with a narrower receptor profile and a defined clinical application.
The reviewed product is given by subcutaneous injection using a single-use autoinjector. Administration occurs under prescription supervision. The device delivers one fixed amount per use rather than a measured or adjustable quantity.
Purity is normally expressed as a percentage of total peak area from a chromatographic run. The value depends on the column, gradient and detection wavelength chosen. Results generated under different conditions are therefore not always interchangeable.